Thomas L Schwartz

Summary

Publications

  1. ncbi request reprint Newly admitted psychiatric patient prescriptions and pharmaceutical sales visits
    T L Schwartz
    Department of Psychiatry, SUNY Upstate Medical University, Syracuse, New York 13210, USA
    Ann Clin Psychiatry 13:159-62. 2001
  2. ncbi request reprint The use of tiagabine augmentation for treatment-resistant anxiety disorders: a case series
    Thomas L Schwartz
    Department of Psychiatry, SUNY Upstate Medical University, 750 East Adams Street, Syracuse, NY 13210, USA
    Psychopharmacol Bull 36:53-7. 2002
  3. ncbi request reprint Use of atypical antipsychotics in a Veterans Affairs hospital
    Thomas L Schwartz
    Department of Psychiatry, SUNY Upstate Medical University, New York, USA
    Prog Neuropsychopharmacol Biol Psychiatry 26:1207-10. 2002
  4. ncbi request reprint An open-label study to evaluate switching from an SSRI or SNRI to tiagabine to alleviate antidepressant-induced sexual dysfunction in generalized anxiety disorder
    Thomas L Schwartz
    Department of Psychiatry, SUNY Upstate Medical University, Syracuse, NY 13210, USA
    Ann Clin Psychiatry 19:25-30. 2007
  5. ncbi request reprint An open-label study of tiagabine as augmentation therapy for anxiety
    Thomas L Schwartz
    SUNY Upstate Medical University, Department of Psychiatry, 750 East Adams Street, Syracuse, NY 13210, USA
    Ann Clin Psychiatry 17:167-72. 2005
  6. doi request reprint Obesity and psychotropics
    Nikhil Nihalani
    SUNY Upstate Medical University, NY, USA
    CNS Neurosci Ther 18:57-63. 2012
  7. doi request reprint Psychiatric resident and attending diagnostic and prescribing practices
    Adam C Tripp
    SUNY Upstate Medical University, Syracuse, NY 13210, USA
    Acad Psychiatry 32:214-7. 2008
  8. ncbi request reprint Tiagabine in anxiety disorders
    Thomas L Schwartz
    Department of Psychiatry, SUNY Upstate Medical University, 750 East Adams Street, Syracuse, NY, USA
    Expert Opin Pharmacother 7:1977-87. 2006
  9. ncbi request reprint Obesity in adults with serious and persistent mental illness: a review of postulated mechanisms and current interventions
    James L Megna
    Department of Psychiatry, SUNY Upstate Medical University, Syracuse, NY, USA
    Ann Clin Psychiatry 23:131-40. 2011
  10. ncbi request reprint The role of atypical antipsychotics in the treatment of delirium
    Thomas L Schwartz
    Department of Psychiatry, S U N Y Upstate Medical University, Syracuse 13210, USA
    Psychosomatics 43:171-4. 2002

Collaborators

Detail Information

Publications23

  1. ncbi request reprint Newly admitted psychiatric patient prescriptions and pharmaceutical sales visits
    T L Schwartz
    Department of Psychiatry, SUNY Upstate Medical University, Syracuse, New York 13210, USA
    Ann Clin Psychiatry 13:159-62. 2001
    ..Furthermore, as sales visits increase in frequency, more of their medications may be started in newly admitted psychiatric outpatients...
  2. ncbi request reprint The use of tiagabine augmentation for treatment-resistant anxiety disorders: a case series
    Thomas L Schwartz
    Department of Psychiatry, SUNY Upstate Medical University, 750 East Adams Street, Syracuse, NY 13210, USA
    Psychopharmacol Bull 36:53-7. 2002
    ..Like other anticonvulsant agents, tiagabine has been explored for use as a mood stabilizer and in panic disorder. This article presents a case series of five patients who were prescribed tiagabine for treatment-resistant anxiety...
  3. ncbi request reprint Use of atypical antipsychotics in a Veterans Affairs hospital
    Thomas L Schwartz
    Department of Psychiatry, SUNY Upstate Medical University, New York, USA
    Prog Neuropsychopharmacol Biol Psychiatry 26:1207-10. 2002
    ....
  4. ncbi request reprint An open-label study to evaluate switching from an SSRI or SNRI to tiagabine to alleviate antidepressant-induced sexual dysfunction in generalized anxiety disorder
    Thomas L Schwartz
    Department of Psychiatry, SUNY Upstate Medical University, Syracuse, NY 13210, USA
    Ann Clin Psychiatry 19:25-30. 2007
    ....
  5. ncbi request reprint An open-label study of tiagabine as augmentation therapy for anxiety
    Thomas L Schwartz
    SUNY Upstate Medical University, Department of Psychiatry, 750 East Adams Street, Syracuse, NY 13210, USA
    Ann Clin Psychiatry 17:167-72. 2005
    ..Gamma-aminobutyric acid (GABA) is the major inhibitory neurotransmitter in the CNS, and agents that modulate GABA neurotransmission have shown promise in the treatment of anxiety disorders and are often used as augmentation agents...
  6. doi request reprint Obesity and psychotropics
    Nikhil Nihalani
    SUNY Upstate Medical University, NY, USA
    CNS Neurosci Ther 18:57-63. 2012
    ..This article serves to provide a succinct review regarding the epidemiology, etiology, and treatment options for psychotropic-induced obesity...
  7. doi request reprint Psychiatric resident and attending diagnostic and prescribing practices
    Adam C Tripp
    SUNY Upstate Medical University, Syracuse, NY 13210, USA
    Acad Psychiatry 32:214-7. 2008
    ..This study investigates whether two patient population groups, under resident or attending treatment, are equivalent or different in the distribution of patient characteristics, diagnoses, or pharmacotherapy...
  8. ncbi request reprint Tiagabine in anxiety disorders
    Thomas L Schwartz
    Department of Psychiatry, SUNY Upstate Medical University, 750 East Adams Street, Syracuse, NY, USA
    Expert Opin Pharmacother 7:1977-87. 2006
    ..Tiagabine may be a useful addition to currently available drugs for anxiety; however, the data from small open-label investigations remain to be confirmed in larger controlled studies...
  9. ncbi request reprint Obesity in adults with serious and persistent mental illness: a review of postulated mechanisms and current interventions
    James L Megna
    Department of Psychiatry, SUNY Upstate Medical University, Syracuse, NY, USA
    Ann Clin Psychiatry 23:131-40. 2011
    ..However, these effects have been more widespread among adults with serious and persistent mental illness...
  10. ncbi request reprint The role of atypical antipsychotics in the treatment of delirium
    Thomas L Schwartz
    Department of Psychiatry, S U N Y Upstate Medical University, Syracuse 13210, USA
    Psychosomatics 43:171-4. 2002
    ..g., schizophrenia or bipolar disorder), but few studies have evaluated them in the treatment of delirium. This paper reviews the pertinent literature and summarizes tentative guidelines for novel antipsychotic use in delirium...
  11. ncbi request reprint Does a preexisting anxiety disorder predict response to paroxetine in irritable bowel syndrome?
    Prakash S Masand
    Department of Psychiatry, Duke University Medical Center, Durham, NC 27710, USA
    Psychosomatics 43:451-5. 2002
    ..Both groups had similar improvement in abdominal pain, constipation, diarrhea, incomplete emptying, and bloating/ abdominal distension. Paroxetine was very well tolerated...
  12. ncbi request reprint Prescribing conventional antipsychotics in the era of novel antipsychotics: informed consent issues
    Prakash S Masand
    Duke University Medical Center, Department of Psychiatry, Durham, North Carolina, USA
    Am J Ther 9:484-7. 2002
    ..066, df = 2, Pearson chi(2) test). For patients who are receiving any antipsychotic therapy, discussions about the risks/benefits of treatments are integral for optimal treatment and medicolegal purposes...
  13. ncbi request reprint An open-label study of adjunctive modafinil in patients with sedation related to serotonergic antidepressant therapy
    Thomas L Schwartz
    Department of Psychiatry, State University of New York Upstate Medical University, Syracuse, NY 13210, USA
    J Clin Psychiatry 65:1223-7. 2004
    ..This study assessed the use of modafinil as an adjunctive treatment in patients with MDD who reported sedation related to serotonergic antidepressant therapy...
  14. ncbi request reprint Modafinil treatment for fatigue associated with fibromyalgia
    Thomas L Schwartz
    Department of Psychiatry, SUNY Upstate Medical Univeristy, Syracuse, New York 13210, USA
    J Clin Rheumatol 13:52. 2007
  15. pmc Glutamate neurocircuitry: theoretical underpinnings in schizophrenia
    Thomas L Schwartz
    Department of Psychiatry, State University of New York Upstate Medical University Syracuse, NY, USA
    Front Pharmacol 3:195. 2012
    ..In conclusion, there is a brief review of potential schizophrenia treatments that rely on the etiologic theory provided in the body of the paper...
  16. ncbi request reprint Gamma hydroxy butyric acid and sodium oxybate used to treat posttraumatic stress disorder
    Thomas L Schwartz
    Department of Psychiatry, State University of New York, Upstate Medical University, Syracuse, New York, USA
    CNS Spectr 12:884-6. 2007
  17. doi request reprint Acamprosate calcium as augmentation therapy for anxiety disorders
    Thomas L Schwartz
    Psychiatry Department, State University of New York SUNY Upstate Medical University, Syracuse, NY, USA
    Ann Pharmacother 44:1930-2. 2010
    ..This GABA-glutamate imbalance is thought to play a role in the development of anxiety. Acamprosate calcium is thought to restore this chemical imbalance in alcohol withdrawal...
  18. pmc Weight gain, obesity, and psychotropic prescribing
    Nikhil Nihalani
    SUNY Upstate Medical University, Syracuse, NY 13210, USA
    J Obes 2011:893629. 2011
    ..The authors undertook a comprehensive literature review in order to present epidemiology, etiology, and treatment options of weight gain associated with antipsychotics, mood stabilizers, and antidepressants...
  19. doi request reprint A neuroscientific update on monoamine oxidase and its inhibitors
    Thomas L Schwartz
    Psychiatry Department, SUNY Upstate Medical University, Syracuse, New York, USA
    CNS Spectr 18:25-32; quiz 33. 2013
    ..These findings and theories will next be translationally discussed in regard to clinical application pertaining to enzyme inhibition and the treatment of major depressive and other psychiatric disorders. ..
  20. ncbi request reprint Psychotropic drug-induced weight gain alleviated with orlistat: a case series
    Thomas L Schwartz
    Upstate Medical University, State University of New York, Syracuse, New York, USA
    Psychopharmacol Bull 37:5-9. 2003
    ..The results showed that orlistat, administered in 3 daily doses with meals, was safe, well-tolerated, and effective, resulting in an average weight loss of 35% during an acute treatment period of about 3 months...
  21. ncbi request reprint Genetic data supporting the NMDA glutamate receptor hypothesis for schizophrenia
    Thomas L Schwartz
    SUNY Upstate Medical University, 750 East Adams Street, Syracuse, NY 13210, USA
    Curr Pharm Des 18:1580-92. 2012
    ..This paper seeks to describe and discuss the potential underlying genetic vulnerabilities of the NMDA receptor and how aberrant genes coding for this receptor may lead to schizophrenia symptoms...
  22. ncbi request reprint Ziprasidone treatment of delirium
    Laura Leso
    SUNY Upstate Medical University, 750 East Adams Street, Syracuse, NY 13210, USA
    Psychosomatics 43:61-2. 2002
  23. ncbi request reprint Modafinil in the treatment of depression with severe comorbid medical illness
    Thomas L Schwartz
    Psychosomatics 43:336-7. 2002